Mark Feneley

1.8k total citations
65 papers, 1.3k citations indexed

About

Mark Feneley is a scholar working on Pulmonary and Respiratory Medicine, Surgery and Urology. According to data from OpenAlex, Mark Feneley has authored 65 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 35 papers in Pulmonary and Respiratory Medicine, 21 papers in Surgery and 12 papers in Urology. Recurrent topics in Mark Feneley's work include Prostate Cancer Diagnosis and Treatment (28 papers), Prostate Cancer Treatment and Research (23 papers) and Bladder and Urothelial Cancer Treatments (13 papers). Mark Feneley is often cited by papers focused on Prostate Cancer Diagnosis and Treatment (28 papers), Prostate Cancer Treatment and Research (23 papers) and Bladder and Urothelial Cancer Treatments (13 papers). Mark Feneley collaborates with scholars based in United Kingdom, United States and Norway. Mark Feneley's co-authors include Roger Kirby, James W. Fawcett, Roger J. Keynes, Malcolm Carruthers, Jason Constantinou, John R. Masters, Alex Freeman, John D. Kelly, Patrick C. Walsh and Wei Shen Tan and has published in prestigious journals such as Proceedings of the National Academy of Sciences, The Lancet and PLoS ONE.

In The Last Decade

Mark Feneley

64 papers receiving 1.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Mark Feneley United Kingdom 23 525 380 309 293 205 65 1.3k
S. Bruce Malkowicz United States 21 349 0.7× 264 0.7× 190 0.6× 381 1.3× 128 0.6× 59 1.2k
Kazuhiro Yoshimura Japan 20 431 0.8× 391 1.0× 110 0.4× 281 1.0× 95 0.5× 135 1.3k
Francesco Pinto Italy 22 689 1.3× 326 0.9× 444 1.4× 368 1.3× 433 2.1× 87 1.5k
S. Machtens Germany 25 627 1.2× 335 0.9× 266 0.9× 491 1.7× 165 0.8× 89 1.8k
Jon Oxley United Kingdom 18 395 0.8× 226 0.6× 90 0.3× 384 1.3× 114 0.6× 54 1.1k
Tony T. Wu Taiwan 15 542 1.0× 156 0.4× 100 0.3× 382 1.3× 95 0.5× 32 1.1k
S. Jacobs United States 23 242 0.5× 223 0.6× 298 1.0× 152 0.5× 109 0.5× 46 1.3k
J. Fenimore Cooper United States 16 323 0.6× 232 0.6× 92 0.3× 668 2.3× 101 0.5× 38 1.4k
Martti Nurmi Finland 23 859 1.6× 440 1.2× 225 0.7× 649 2.2× 73 0.4× 56 2.0k
Philippe Berthon France 24 725 1.4× 120 0.3× 90 0.3× 867 3.0× 49 0.2× 56 1.6k

Countries citing papers authored by Mark Feneley

Since Specialization
Citations

This map shows the geographic impact of Mark Feneley's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark Feneley with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark Feneley more than expected).

Fields of papers citing papers by Mark Feneley

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mark Feneley. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark Feneley. The network helps show where Mark Feneley may publish in the future.

Co-authorship network of co-authors of Mark Feneley

This figure shows the co-authorship network connecting the top 25 collaborators of Mark Feneley. A scholar is included among the top collaborators of Mark Feneley based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mark Feneley. Mark Feneley is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Feneley, Mark, et al.. (2019). Comparative Outcomes of Bladder Cancer in Patients Under 40 Years of Age. 2(4). e10–e19. 1 indexed citations
2.
3.
Symes, Andrew, Michael Millar, Joseph Nariculam, et al.. (2013). Quantitative Analysis of BTF3, HINT1, NDRG1 and ODC1 Protein Over-Expression in Human Prostate Cancer Tissue. PLoS ONE. 8(12). e84295–e84295. 43 indexed citations
4.
Shabbir, Majid, et al.. (2010). Palliation of Male Genital Cancers. Clinical Oncology. 22(9). 747–754. 5 indexed citations
5.
Foley, Charlotte & Mark Feneley. (2009). The clinical significance and therapeutic implications of extraprostatic invasion. Surgical Oncology. 18(3). 203–212. 2 indexed citations
6.
Feneley, Mark, et al.. (2008). Prostate cancer: diagnosis and staging. Asian Journal of Andrology. 11(1). 74–80. 69 indexed citations
7.
8.
Harada, Masahiko, Josephine Woodhams, Alexander J. MacRobert, et al.. (2004). The vascular response to photodynamic therapy with ATX-S10Na(II) in the normal rat colon. Journal of Photochemistry and Photobiology B Biology. 79(3). 223–230. 11 indexed citations
9.
Yung, Andrew, Ali Yusuf Öner, Jean‐Michel Serfaty, et al.. (2003). Phased‐array MRI of canine prostate using endorectal and endourethral coils. Magnetic Resonance in Medicine. 49(4). 710–715. 6 indexed citations
10.
Feneley, Mark & Simon Brewster. (2003). Opportunities and outcomes in early prostate cancer: a commentary on policy, patient perspectives, trials and strategies. British Journal of Urology. 91(3). 177–178. 3 indexed citations
11.
Feneley, Mark & S.J. Harland. (2003). Neoadjuvant chemotherapy for muscle‐invasive bladder cancer: a new standard of care?. British Journal of Urology. 92(9). 877–878. 4 indexed citations
12.
Feneley, Mark & Alan W. Partin. (2001). INDICATORS OF PATHOLOGIC STAGE OF PROSTATE CANCER AND THEIR USE IN CLINICAL PRACTICE. Urologic Clinics of North America. 28(3). 443–458. 13 indexed citations
13.
Feneley, Mark & Alan W. Partin. (2000). Diagnosis of localized prostate cancer: 10 years of progress. Current Opinion in Urology. 10(4). 319–327. 11 indexed citations
14.
Britton, K. E., et al.. (2000). Prostate cancer: the contribution of nuclear medicine. British Journal of Urology. 86(s1). 135–142. 7 indexed citations
15.
Feneley, Mark, Patricia Landis, Inpakala Simon, et al.. (2000). Today men with prostate cancer have larger prostates. Urology. 56(5). 839–842. 28 indexed citations
16.
Feneley, Mark & Patrick C. Walsh. (1999). Incontinence after radical prostatectomy. The Lancet. 353(9170). 2091–2092. 31 indexed citations
17.
Feneley, Mark. (1998). Electrovaporisation of the prostate. The Lancet. 351(9108). 999–1001. 2 indexed citations
18.
Feneley, Mark, Vaseem Chengazi, Roger Kirby, et al.. (1996). Prostatic radioimmunoscintigraphy: preliminary results using technetium‐labelled monoclonal antibody, CYT‐351. British Journal of Urology. 77(3). 373–381. 11 indexed citations
19.
Feneley, Mark, et al.. (1995). Post‐operative serial prostate‐specific antigen and transrectal ultrasound for staging incidental carcinoma of the prostate. British Journal of Urology. 75(1). 14–20. 5 indexed citations
20.
Feneley, Mark, James W. Fawcett, & Roger J. Keynes. (1991). The role of Schwann cells in the regeneration of peripheral nerve axons through muscle basal lamina grafts. Experimental Neurology. 114(3). 275–285. 98 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by S. Bruce Malkowicz Breakdown of academic impact, for papers by Kazuhiro Yoshimura Breakdown of academic impact, for papers by Francesco Pinto Breakdown of academic impact, for papers by S. Machtens Breakdown of academic impact, for papers by Jon Oxley Breakdown of academic impact, for papers by Tony T. Wu Breakdown of academic impact, for papers by S. Jacobs Breakdown of academic impact, for papers by J. Fenimore Cooper Breakdown of academic impact, for papers by Martti Nurmi Breakdown of academic impact, for papers by Philippe Berthon
Rankless by CCL
2026